KOLOA, Hawaii — Data from various retinal clinical trials suggest that there is a difference in efficacy in anti-VEGF therapies for patients with lower vision, according to a speaker here. KOLOA ...

Vitreous Glass ( CVE:VCI ) Full Year 2024 Results Key Financial Results Revenue: CA$9.66m (down 5.2% from FY 2023). Net... Key Insights Vitreous Glass' estimated fair value is CA$5.67 based on 2 ...

We get floaters when vitreous fibres - a gel-like fluid that makes up 80 per cent of the eye - clog together, according to ...